AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Galvamark Met 1000mg/50mg Tablet

Prescription Icon
Prescription Required

Marketer

Glenmark Pharmaceuticals Ltd

Salt Composition

Metformin (1000mg) + Vildagliptin (50mg)

Overview Galvamark Met 1000mg/50mg Tablet

Metformin-based Duotab 1000mg/50mg effectively manages elevated blood glucose in individuals with type 2 diabetes. This dual-action formulation helps mitigate severe diabetic complications like renal impairment and vision loss, potentially lowering cardiovascular event risk. Prescribed independently or in conjunction with other antidiabetic agents, Duotab 1000mg/50mg achieves optimal efficacy when coupled with a balanced diet and regular physical activity. Dosage is personalized based on individual health status, glucose readings, and concurrent medications. Consuming the tablet with food minimizes gastrointestinal distress. Consistent daily administration at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Maintaining controlled blood sugar levels prevents future complications. Adherence to the prescribed diet and exercise plan is crucial for successful diabetes management, as lifestyle significantly impacts glycemic control. Commonly reported side effects encompass diarrhea, nausea, emesis, dyspepsia, cephalalgia, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia, a potential adverse effect when used with insulin or sulfonylureas, necessitates patient awareness of its symptoms and management. This medication isn't universally suitable. Prior to commencing treatment, disclose any history of renal, hepatic, or cardiac disease, pancreatic issues, or significant alcohol consumption to your physician. Pregnant or lactating individuals require medical consultation before initiating treatment. Potential drug interactions mandate comprehensive medication disclosure to ensure patient safety. Alcohol consumption should be minimized due to its hypoglycemic effects. Renal function and blood glucose levels will be monitored by your doctor throughout the treatment period.

Primary Ingredients of Galvamark Met 1000mg/50mg Tablet

The provided text is "undefined," which lacks meaning and cannot be rephrased.

Uses of Galvamark Met 1000mg/50mg Tablet

Managing type 2 diabetes

Major Benefits of Galvamark Met 1000mg/50mg Tablet:

Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Galvamark Met 1000mg/50mg Tablet with a meal.

Common Side effects of Galvamark Met 1000mg/50mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Galvamark Met 1000mg/50mg Tablet:

Consume Galvamark Met 1000mg/50mg tablets as prescribed by your physician, adhering to the recommended dosage and treatment schedule. Ingest the tablets whole; avoid chewing, crushing, or fracturing them. Administer with a meal.

How Galvamark Met 1000mg/50mg Tablet works:

Metformin and Glimepiride 1000mg/50mg tablets, marketed as Galvamark Met, offer dual antidiabetic action.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Galvamark Met 1000mg/50mg Tablet ingestion poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Galvamark Met 1000mg/50mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Patient consultation with their doctor is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Galvamark Met 1000mg/50mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Galvamark Met 1000mg/50mg Tablets cautiously, potentially requiring dosage modification. Physician consultation is advised.

LiverLiverUNSAFE

Use of Galvamark Met 1000mg/50mg tablets in individuals with hepatic impairment is likely inadvisable and should be avoided. Seek medical advice.

What if you forget to take Galvamark Met 1000mg/50mg Tablet :

Should you forget to take your Galvamark Met 1000mg/50mg Tablet, administer it immediately upon remembering. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed dose.

Facts to Know About Galvamark Met 1000mg/50mg Tablet

LabelValue
Developing Habits No.
Type of Treatment Diabetes Management

FAQs on Galvamark Met 1000mg/50mg Tablet

Galvamark Met 1000mg/50mg tablets rarely cause hypoglycemia by themselves; however, insufficient caloric intake while using this medication may lead to low blood sugar. Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. These symptoms are more pronounced if meals are skipped or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Galvamark Met 1000mg/50mg Tablets. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take additional medication without your doctor's advice.
Galvamark Met 1000mg/50mg Tablets are contraindicated in patients allergic to any of its components. This medication should also not be used by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Galvamark Met 1000mg/50mg tablets combine metformin (a biguanide) and vildagliptin to manage diabetes. Metformin reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Galvamark Met 1000mg/50mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue use and seek immediate medical attention.
Prolonged use of Galvamark Met 1000mg/50mg tablets can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Using Galvamark Met 1000mg/50mg Tablet as directed by your doctor is safe. However, even with correct dosage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (especially if using insulin or sulphonylurea) may occur. Report any persistent issues to your doctor.
Galvamark Met 1000mg/50mg...
96
MRP 117
17% off